A detailed history of Unisphere Establishment transactions in Novo Nordisk A S stock. As of the latest transaction made, Unisphere Establishment holds 97,500 shares of NVO stock, worth $8.52 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
97,500
Previous 97,500 -0.0%
Holding current value
$8.52 Million
Previous $13.9 Million 16.58%
% of portfolio
0.11%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $4.34 Million - $5.78 Million
42,500 Added 77.27%
97,500 $12.5 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $4.83 Million - $5.8 Million
55,000 New
55,000 $5.69 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Unisphere Establishment Portfolio

Follow Unisphere Establishment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unisphere Establishment, based on Form 13F filings with the SEC.

News

Stay updated on Unisphere Establishment with notifications on news.